Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2659

Actual shortage: 251 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2399 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

329 (11%)

Overdue reports

27 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-LEVOCARBIDOPA 25MG 100MG TABLET Resolved 2019-09-26 2019-10-10 94864
TEVA-LEVOCARBIDOPA 25MG 100MG TABLET Actual shortage 2019-11-28 2022-08-18 99935
TEVA-LEVOCARBIDOPA 25MG 100MG TABLET Actual shortage 2019-12-05 2022-08-18 100299
TEVA-VALSARTAN/HCTZ 25MG 160MG TABLET Actual shortage 2018-10-23 2019-07-15 65372
TEVA-VALSARTAN/HCTZ 25MG 160MG TABLET Actual shortage 2018-10-23 2019-07-15 65375
TEVA-LISINOPRIL/HCTZ (TYPE Z) 25MG 20MG TABLET Resolved 2019-10-31 2020-04-23 97628
TEVA-LISINOPRIL/HCTZ (TYPE Z) 25MG 20MG TABLET Resolved 2023-02-02 2023-02-16 183398
TEVA-LISINOPRIL/HCTZ (TYPE Z) 25MG 20MG TABLET Resolved 2023-06-08 2023-06-27 194122
TEVA-LISINOPRIL/HCTZ (TYPE Z) 25MG 20MG TABLET Resolved 2023-06-16 2023-06-27 195124
TEVA-LISINOPRIL/HCTZ (TYPE Z) 25MG 20MG TABLET Resolved 2023-06-16 2023-06-27 195204
TEVA-LISINOPRIL/HCTZ (TYPE Z) 25MG 20MG TABLET Resolved 2023-07-04 2023-08-04 197104
TEVA-LISINOPRIL/HCTZ (TYPE Z) 25MG 20MG TABLET Resolved 2023-08-17 2023-10-04 202278
TEVA-LEVOCARBIDOPA 25MG 250MG TABLET Resolved 2017-08-01 2018-02-22 17896
TEVA-LEVOCARBIDOPA 25MG 250MG TABLET Resolved 2017-08-21 2018-02-22 19973
TEVA-LEVOCARBIDOPA 25MG 250MG TABLET Actual shortage 2020-02-21 2020-03-26 106945
TEVA-SPIRONOLACTONE/HCTZ 25MG 25MG TABLET Resolved 2017-08-02 2017-11-07 18021
TEVA-SPIRONOLACTONE/HCTZ 25MG 25MG TABLET Resolved 2020-04-03 2020-06-04 110785
TEVA-SPIRONOLACTONE/HCTZ 25MG 25MG TABLET Resolved 2020-11-06 2021-02-05 128022
TEVA-SPIRONOLACTONE/HCTZ 25MG 25MG TABLET Resolved 2022-03-24 2022-04-21 157262
TEVA-SPIRONOLACTONE/HCTZ 25MG 25MG TABLET Resolved 2022-12-01 2023-02-16 176842

Showing 1461 to 1480 of 2659

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852
ACT CLOPIDOGREL Discontinued 2018-10-19 2018-10-19 65065
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65284
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65289
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION 0.004% SOLUTION Discontinued 2020-01-21 2020-01-21 103788
TEVA-ECTOSONE 0.1% LOTION Discontinued 2023-12-05 2023-12-05 212526
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.375G 3G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210191
RATIO-TAMSULOSIN 0.4MG CAPSULE (SUSTAINED-RELEASE) Discontinued 2018-10-19 2018-10-19 64917

Showing 21 to 40 of 250